Insider Sell Alert: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United ... [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
Paul Mahon, the company's EVP & General Counsel, sold 6,000 shares of the company on November 16, 2023. This transaction has prompted a closer look into the insider's trading behavior, the company's business operations, and the potential implications for the stock's valuation and performance. Who is Paul Mahon? Warning! GuruFocus has detected 6 Warning Signs with EXPE. Paul Mahon serves as the Executive Vice President and General Counsel for United Therapeutics Corp, a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Mahon's role within the company involves overseeing legal affairs, ensuring compliance with regulatory requirements, and providing strategic counsel to the executive team. His actions, particularly in the realm of stock transactions, are closely monitored by investors as they can provide insights into the company's internal perspectiv
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- S&P 500 Futures Flat in Premarket Trading; United Therapeutics, Intel Lag [Barron's]Barrons
- United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base [Yahoo! Finance]Yahoo! Finance
- United Therapeutics: Growing Company With Great Franchise In Pulmonary Diseases [Seeking Alpha]Seeking Alpha
- United Therapeutics (NASDAQ:UTHR) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 12/29/25 - Form 144
- 12/23/25 - Form 4
- 12/23/25 - Form 4
- UTHR's page on the SEC website